Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents
Authors:
- 1 November 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (21) , 5727-5737
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20130554)
This publication has 30 references indexed in Scilit:
- Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic DevelopmentBioscience, Biotechnology, and Biochemistry, 2006
- The reductase steps of the type II fatty acid synthase as antimicrobial targetsLipids, 2004
- ‘FAS’t inhibition of malariaBiochemical Journal, 2004
- A Type II Pathway for Fatty Acid Biosynthesis Presents Drug Targets in Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2003
- Lipid biosynthesis as a target for antibacterial agentsProgress in Lipid Research, 2001
- Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug DiscoveryAnnual Review of Microbiology, 2001
- Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discoveryDrug Discovery Today, 2001
- Animal fatty acid synthase: Functional mapping and cloning and expression of the domain I constituent activitiesProceedings of the National Academy of Sciences, 1997
- Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- The worldwide prevalence of methicillin-resistant Staphylococcus aureusInternational Journal of Antimicrobial Agents, 1995